Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial
Introduction Communication is an essential aspect of care for patients with progressive serious illnesses. This study aims to evaluate the efficacy of a new, integrated communication support program for oncologists, patients with rapidly progressing advanced cancer and their caregivers.Methods and a...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/9/e036745.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841554162970525696 |
|---|---|
| author | Makoto Ueno Takuhiro Yamaguchi Tempei Miyaji Yosuke Uchitomi Takuji Okusaka Masafumi Ikeda Maiko Fujimori Ayako Sato Sayaka Jinno Masato Ozaka Yukiko Takayama Yoshiyuki Majima |
| author_facet | Makoto Ueno Takuhiro Yamaguchi Tempei Miyaji Yosuke Uchitomi Takuji Okusaka Masafumi Ikeda Maiko Fujimori Ayako Sato Sayaka Jinno Masato Ozaka Yukiko Takayama Yoshiyuki Majima |
| author_sort | Makoto Ueno |
| collection | DOAJ |
| description | Introduction Communication is an essential aspect of care for patients with progressive serious illnesses. This study aims to evaluate the efficacy of a new, integrated communication support program for oncologists, patients with rapidly progressing advanced cancer and their caregivers.Methods and analysis The proposed integrated communication support programme is in the randomised control trial stage. It comprises a cluster of oncologists from comprehensive cancer centre hospitals in a metropolitan area in Japan. A total of 20 oncologists, 200 patients with advanced pancreatic cancer and the patients’ caregivers are enrolled in this study as of the writing of this protocol report. Oncologists are randomly assigned to the intervention group (IG) or control group (CG). Patients and caregivers are allocated to the same group as their oncologists. The IG oncologists receive a 2.5-hour individual communication skills training, and patients and caregivers receive a half-hour coaching intervention to facilitate prioritising and discussing questions and concerns; the CG participants do not receive any training. Follow-up data will be collected quarterly for 6 months for a year and then annually for up to 3 years. The primary endpoint is the intergroup difference between before-intervention and after-intervention patient-centred communication behaviours during oncology visits.Ethics and dissemination This study is conducted in accordance with the ethical guidelines for clinical studies published by Japan’s Ministry of Education, Cultural, Sports, Science and Technology, the Ministry of Health, Labour and Welfare, and the ethical principles established for research on humans stipulated in the Declaration of Helsinki and further amendments thereto. The protocol was approved by the Institutional Review Board of National Cancer Center, Japan on 4 July 2018 (ID: 2017-474).Trial status This study is currently enrolling participants. Enrolment period ends 31 July 2020; estimated follow-up date is 31 March 2023.Trial registration number UMIN Clinical Trial Registry (UMIN000033612); pre-results. |
| format | Article |
| id | doaj-art-22d51ed7d1db4ea2a92accddf6690a36 |
| institution | Kabale University |
| issn | 2044-6055 |
| language | English |
| publishDate | 2020-09-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-22d51ed7d1db4ea2a92accddf6690a362025-01-08T18:25:07ZengBMJ Publishing GroupBMJ Open2044-60552020-09-0110910.1136/bmjopen-2019-036745Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trialMakoto Ueno0Takuhiro Yamaguchi1Tempei Miyaji2Yosuke Uchitomi3Takuji Okusaka4Masafumi Ikeda5Maiko Fujimori6Ayako Sato7Sayaka Jinno8Masato Ozaka9Yukiko Takayama10Yoshiyuki Majima11Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Yokohama, Japan9Division of Biostatistics, Tohoku University Graduate School of Medicine, Miyagi, JapanDepartment of Clinical Trial Data Management, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, JapanInnovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Chuo-ku, JapanDepartment of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Japan15National Cancer Center Hospital East, Kashiwa, JapanDivision of Survivorship Research, Institute for Cancer Control, National Cancer Center, Tokyo, JapanDivision of Survivorship Research, Institute for Cancer Control, National Cancer Center, Tokyo, JapanDivision of Health Care Research, Center for Public Health Sciences, National Cancer Center, Chuo-ku, JapanDepartment of Hepatobiliary and Pancreatic Medical Oncology, Public Interest Incorporated Foundation Cancer Institute Hospital of JFCR, Koto-ku, JapanDepartment of Medicine, Institute of Gastroenterology, Tokyo Women’s Medical University Hospital, Shinjuku-ku, JapanNPO Pancreatic Cancer Action Network Japan, Tokyo, UKIntroduction Communication is an essential aspect of care for patients with progressive serious illnesses. This study aims to evaluate the efficacy of a new, integrated communication support program for oncologists, patients with rapidly progressing advanced cancer and their caregivers.Methods and analysis The proposed integrated communication support programme is in the randomised control trial stage. It comprises a cluster of oncologists from comprehensive cancer centre hospitals in a metropolitan area in Japan. A total of 20 oncologists, 200 patients with advanced pancreatic cancer and the patients’ caregivers are enrolled in this study as of the writing of this protocol report. Oncologists are randomly assigned to the intervention group (IG) or control group (CG). Patients and caregivers are allocated to the same group as their oncologists. The IG oncologists receive a 2.5-hour individual communication skills training, and patients and caregivers receive a half-hour coaching intervention to facilitate prioritising and discussing questions and concerns; the CG participants do not receive any training. Follow-up data will be collected quarterly for 6 months for a year and then annually for up to 3 years. The primary endpoint is the intergroup difference between before-intervention and after-intervention patient-centred communication behaviours during oncology visits.Ethics and dissemination This study is conducted in accordance with the ethical guidelines for clinical studies published by Japan’s Ministry of Education, Cultural, Sports, Science and Technology, the Ministry of Health, Labour and Welfare, and the ethical principles established for research on humans stipulated in the Declaration of Helsinki and further amendments thereto. The protocol was approved by the Institutional Review Board of National Cancer Center, Japan on 4 July 2018 (ID: 2017-474).Trial status This study is currently enrolling participants. Enrolment period ends 31 July 2020; estimated follow-up date is 31 March 2023.Trial registration number UMIN Clinical Trial Registry (UMIN000033612); pre-results.https://bmjopen.bmj.com/content/10/9/e036745.full |
| spellingShingle | Makoto Ueno Takuhiro Yamaguchi Tempei Miyaji Yosuke Uchitomi Takuji Okusaka Masafumi Ikeda Maiko Fujimori Ayako Sato Sayaka Jinno Masato Ozaka Yukiko Takayama Yoshiyuki Majima Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial BMJ Open |
| title | Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial |
| title_full | Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial |
| title_fullStr | Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial |
| title_full_unstemmed | Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial |
| title_short | Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial |
| title_sort | integrated communication support program for oncologists caregivers and patients with rapidly progressing advanced cancer to promote patient centered communication j support 1904 study protocol for a randomised controlled trial |
| url | https://bmjopen.bmj.com/content/10/9/e036745.full |
| work_keys_str_mv | AT makotoueno integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT takuhiroyamaguchi integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT tempeimiyaji integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT yosukeuchitomi integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT takujiokusaka integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT masafumiikeda integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT maikofujimori integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT ayakosato integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT sayakajinno integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT masatoozaka integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT yukikotakayama integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial AT yoshiyukimajima integratedcommunicationsupportprogramforoncologistscaregiversandpatientswithrapidlyprogressingadvancedcancertopromotepatientcenteredcommunicationjsupport1904studyprotocolforarandomisedcontrolledtrial |